Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea
2
조회
0
다운로드
54
인용
0
참고문헌
키워드
초록
The outbreak of coronavirus disease 2019 (COVID-19), which began in December 2019, is still ongoing in Korea, with >9,000 confirmed cases as of March 25, 2020. COVID-19 is a severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection, and real-time reverse transcription-PCR is currently the most reliable diagnostic method for COVID-19 around the world. Korean Society for Laboratory Medicine and the Korea Centers for Disease Prevention and Control propose guidelines for diagnosing COVID-19 in clinical laboratories in Korea. These guidelines are based on other related domestic and international guidelines, as well as expert opinions and include the selection of test subjects, selection of specimens, diagnostic methods, interpretation of test results, and biosafety.
Abstract
The outbreak of coronavirus disease 2019 (COVID-19), which began in December 2019, is still ongoing in Korea, with >9,000 confirmed cases as of March 25, 2020. COVID-19 is a severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection, and real-time reverse transcription-PCR is currently the most reliable diagnostic method for COVID-19 around the world. Korean Society for Laboratory Medicine and the Korea Centers for Disease Prevention and Control propose guidelines for diagnosing COVID-19 in clinical laboratories in Korea. These guidelines are based on other related domestic and international guidelines, as well as expert opinions and include the selection of test subjects, selection of specimens, diagnostic methods, interpretation of test results, and biosafety.
참고문헌 (30)
- Chen N, "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study", Lancet, 395, pp.507~513 (2020)
- Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, "The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2", Nature Microbiology, 5(4), pp.536~544 (2020), Springer Science and Business Media LLC[DOI]
- "Guidelines in response to coronavirus disease 2019"[URL]
- "Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance"[URL]
- Chu DKW, "Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia", Clin Chem (2020)[DOI]
- Corman VM, "Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR", Euro Surveill, 25, pp.2000045~ (2020)
- "Diagnostic detection of novel coronavirus 2019 by real time RT-PCR"[URL]
- "Protocol: real-time RT-PCR assays for the detection of SARS-CoV-2"[URL]
- "Real-time RT-PCR panel for detection 2019-Novel Coronavirus"[URL]
- Wang D, "Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China", JAMA (2020)[DOI]
- Zhu N, "A novel coronavirus from patients with pneumonia in China, 2019", N Engl J Med, 382, pp.727~733 (2020)
- "Specific primers and probes for detection 2019 novel coronavirus"[URL]
- Vijgen L, "A pancoronavirus RT-PCR assay for detection of all known coronaviruses", Methods Mol Biol, 454, pp.3~12 (2008)
- "Coronavirus disease (COVID-19) technical guidance: laboratory testing for 2019-nCoV in humans"[URL]
- "Guidance COVID-19: safe handling and processing for laboratories"[URL]
- "Coronavirus disease 2019 (COVID-19) testing"[URL]
- Zou L, "SARS-CoV-2 viral load in upper respiratory specimens of infected patients", N Engl J Med, 382, pp.1177~1179 (2020)
- "Guidelines for collecting clinical specimens for 2019 novel Coronavirus"[URL]
- "Interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19)"[URL]
- 기창석, "Korean Society for Laboratory Medicine Practice Guidelines for the Molecular Diagnosis of Middle East Respiratory Syndrome During an Outbreak in Korea in 2015", Annals of Laboratory Medicine, 36(3), pp.203~208 (2016), 대한진단검사의학회
- "Guidance for laboratory biosafety related to coronavirus disease 2019"[URL]
- Chosewood CL, "Biosafety in microbiological and biomedical laboratories", United States Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institutes of Health, ~ (2009)
- "Laboratory biosafety guidance related to coronavirus disease 2019 (COVID-19): interim guidance"[URL]
- "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)"[URL]
- "Specific measures for the management of coronavirus disease 2019 quarantine medical waste"[URL]
- CLSI, "Molecular diagnostic methods for infectious diseases" (2015), Clinical and Laboratory Standards Institute
- "Laboratory biosafety manual" (2004)[URL]
- "Requirements and technical specifications of personal protective equipment (PPE) for the novel coronavirus (2019-ncov) in healthcare settings"[URL]
- "Rational use of personal protective equipment (PPE) for coronavirus disease (COVID-19): interim guidance"[URL]
- "Infection prevention and control during health care when COVID-19 is suspected: interim guidance"[URL]
